Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTSJH2W)

• DTT Name: Mitochondrial protein unspecific (MP)
• Gene Name: NO-GeName
• DTT Type: Clinical trial target; [1]
• Related Disease:
  Alzheimer disease [ICD-11: 8A20]
  Type 2 diabetes mellitus [ICD-11: 5A11]
  Ataxic disorder [ICD-11: 8A03]
  Muscular dystrophy [ICD-11: 8C70]
• UniProt ID: NOUNIPROTAC
• TTD ID: T88537

Molecular Interaction Atlas (MIA) of This DTT

2 Clinical Trial Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Mitoglitazone	DMIRPSA	Alzheimer disease	8A20	Phase 2	[1], [2]
Epicatechin	DMN0EMP	Duchenne dystrophy	8C70	Phase 1/2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)